GI-MAP (Gastrointestinal Microbial Assay Plus)
Comprehensive panel for intestinal microorganism analysis, immune and digestive markers
Gastrointestinal Microbial Assay Plus (GI-MAP) is an innovative clinical tool that measures the DNA of the gastrointestinal microbiota from a single stool sample, using modern qPCR (quantitative polymerase chain reaction) technology.
The GI-MAP test was designed to detect microorganisms that can disrupt the balance of the intestinal microbiota or contribute to the development of certain conditions, as well as to evaluate indicators of:
- digestion
- nutrient absorption
- inflammation
- immune system function
In the case of culture-based microbiological tests, strict anaerobes, viruses, or virulence factors cannot be measured. GI-MAP overcomes these limitations.
The accuracy and reliability of the GI-MAP test allow for the development of personalized treatment protocols for intestinal dysfunctions, depending on:
- infections requiring urgent intervention
- areas of the intestinal tract that are already functioning optimally
- aspects that need to be addressed after an infection has been resolved
Also, quantification of identified microorganisms allows for monitoring treatment efficacy. Repeating the test after therapy can show, for example, whether:
- a parasite has been eliminated
- intestinal dysbiosis has improved
- the balance of the microbiota has improved
Indications
The test may be useful in the following situations:
- autoimmune molecular mimicry (if caused by pathogens)
- diarrhea
- digestive problems
- foodborne illnesses
- gastritis
- gastroenteritis (especially of viral origin)
- intestinal dysbiosis
- immune system evaluation
- intestinal inflammation
- suspicion of bacterial, parasitic or viral infections (including detection of antibiotic-resistant bacteria)
